These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Liver as a target for oligonucleotide therapeutics. Sehgal A; Vaishnaw A; Fitzgerald K J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039 [TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges for antisense oligonucleotide therapies. Kuijper EC; Bergsma AJ; Pijnappel WWMP; Aartsma-Rus A J Inherit Metab Dis; 2021 Jan; 44(1):72-87. PubMed ID: 32391605 [TBL] [Abstract][Full Text] [Related]
9. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA. Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483 [TBL] [Abstract][Full Text] [Related]
10. Targeting Alternative Splicing for Therapeutic Interventions. Centa JL; Hastings ML Methods Mol Biol; 2022; 2537():21-36. PubMed ID: 35895256 [TBL] [Abstract][Full Text] [Related]
11. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. Wilton SD; Fletcher S Curr Gene Ther; 2011 Aug; 11(4):259-75. PubMed ID: 21453280 [TBL] [Abstract][Full Text] [Related]
13. Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping. Li D; Mastaglia FL; Fletcher S; Wilton SD Trends Pharmacol Sci; 2018 Nov; 39(11):982-994. PubMed ID: 30282590 [TBL] [Abstract][Full Text] [Related]
14. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. Wilton SD; Fletcher S Curr Gene Ther; 2005 Oct; 5(5):467-83. PubMed ID: 16250888 [TBL] [Abstract][Full Text] [Related]
15. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression. Lee JJA; Saito T; Duddy W; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539 [TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides as therapeutics for malignant diseases. Ho PT; Parkinson DR Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689 [TBL] [Abstract][Full Text] [Related]
18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]